Novo Nordisk Limited

Broadfield Park, Brighton Road, Crawley, West Sussex, RH11 9RT
Telephone: +44 (0)1293 613555
Fax: +44 (0)1293 613535
Medical Information Direct Line: +44 (0)845 600 5055
Medical Information e-mail: ukmedicalinfo@novonordisk.com
Customer Care direct line: +44 (0)845 600 5055
Medical Information Fax: +44 (0)1293 613211

Patient Information Leaflet last updated on the eMC: 23/09/2011
PIL Insulatard

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 28/01/2010 and displayed until 23/09/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to Further Information section
  • Change to date of revision
Updated on 17/08/2006 and displayed until 28/01/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 28/07/2003 and displayed until 17/08/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 22/08/2000 and displayed until 28/07/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   human insulin